Publications by authors named "Tsung Ying Yu"

Chronic lymphocytic leukemia (CLL) is the most common lymphoproliferative disease in adults. Despite durable responses and sustained remission rates to frontline therapy, CLL is still incurable within standard therapy and eventually relapses. Maintenance therapies aim to achieve deep remission.

View Article and Find Full Text PDF

This work investigates the effect of anhydrogen plasma treatment on gate bias stability and performance of amorphous InGaZnO thin-film transistors (TFTs) deposited by using atmospheric-pressure PECVD. The Hplasma-treated-IGZO channel has shown significant improvement in bias stress induced instability with a minuscule threshold voltage shift (Δ) of 0.31 and -0.

View Article and Find Full Text PDF

Hodgkin's lymphoma (HL) is usually sensitive and curative to multi-agent chemotherapy, but may become refractory disease in a subset of relapsed patients. Recent novel agents, brentuximab-vedotin (BV) and immune checkpoint inhibitors have significantly improve the treatment outcome. We report the outcome by combination of BV with pembrolizumab in a patient with a relapsed/refractory HL in a remarkable and durable response, even previously failed to multiple lines of chemotherapy, or brentuximab-vedotin/pembrolizumab monotherapy.

View Article and Find Full Text PDF

Amorphous InGaZnO (a-IGZO) Thin Film Transistors (TFTs) has been studied extensively for their perspective applications in next generation active-matrix displays such as liquid crystal displays and flat-panel displays, due to its better field-effect mobility (>10 cm²/V · S), larger / ratio (>10), and better stability electrical. Hydrogen is known as shallow donors for -type (channel) oxide semiconductors (Dong, J.J.

View Article and Find Full Text PDF